These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19346749)

  • 1. [New developments in ovarian stimulation].
    Griesinger G; Diedrich K
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):55-61. PubMed ID: 19346749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility.
    Loutradis D; Drakakis P; Vlismas A; Antsaklis A
    Curr Opin Investig Drugs; 2009 Apr; 10(4):372-80. PubMed ID: 19337959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.
    Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT
    Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome prevention strategies: individualizing gonadotropin dose.
    Olivennes F
    Semin Reprod Med; 2010 Nov; 28(6):463-7. PubMed ID: 21082504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild ovarian stimulation for IVF.
    Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
    Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation.
    Nardo LG; Fleming R; Howles CM; Bosch E; Hamamah S; Ubaldi FM; Hugues JN; Balen AH; Nelson SM
    Reprod Biomed Online; 2011 Aug; 23(2):141-8. PubMed ID: 21665542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New developments in reproductive medicine].
    Imthurn B; Kimmig R; Lang U; Fink D
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):53-4. PubMed ID: 19346748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tools for optimizing endometrial receptivity in controlled ovarian hyperstimulation: aromatase inhibitors and LH/(mini)hCG.
    de Ziegler D; Mattenberger C; Schwarz C; Ibecheole V; Fournet N; Bianchi-Demicheli F
    Ann N Y Acad Sci; 2004 Dec; 1034():262-77. PubMed ID: 15731318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
    Fauser BC; Diedrich K; Devroey P;
    Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor responder protocols for in-vitro fertilization: options and results.
    Loutradis D; Vomvolaki E; Drakakis P
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternative approaches to ovarian stimulation].
    Alvarez S
    Gynecol Obstet Fertil; 2007 Sep; 35(9):885-9. PubMed ID: 17825596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
    Park JK; Clark R; Session DR
    Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model.
    Fainaru O; Hornstein MD; Folkman J
    Fertil Steril; 2009 Nov; 92(5):1701-5. PubMed ID: 18937946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
    Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
    Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
    Orvieto R; Homburg R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor.
    van de Lagemaat R; Timmers CM; Kelder J; van Koppen C; Mosselman S; Hanssen RG
    Hum Reprod; 2009 Mar; 24(3):640-8. PubMed ID: 19088107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of an ovarian stimulation in case of a Kallmann-De Morsier syndrome. The role of LH].
    Heraud MH; Grenier N; Cabry R; Lourdel E; Sanguinet P; Brasseur F; Henry I; Copin H; Merviel P
    Gynecol Obstet Fertil; 2007 Jun; 35(6):548-55. PubMed ID: 17512237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone patch improves ovarian follicular response to gonadotrophins in a patient with Kallmann's syndrome: a case report.
    Sipe CS; Van Voorhis BJ
    Hum Reprod; 2007 May; 22(5):1380-3. PubMed ID: 17341590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.